CELL LYSIS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2022 to 2030)

Cells contain biomolecules such as proteins or nucleic acids present in the cytoplasm and enclosed within a membrane. Cell lysis is a process in which a cell membrane is ruptured due to some external forces or conditions such as viral infection or osmosis, resulting in the release of cell contents, thus resulting in subsequent death of the cell. In pharmaceutical and biotechnology industries and research laboratories, cell lysis is often used to break open the cell to study its internal components. The two methods through which cell lysis can be achieved include mechanical and chemical methods. Mechanical cell lysis method includes high shear mixing, sonication, freeze or thaw cycles, traditional homogenization, grinding, and high pressure homogenization whereas, chemical lysis method comprises osmotic lysis, and use of detergents and chelating agents.

Cell lysis is an essential unit operation for molecular diagnostics of pathogens and immunoassays for point of care diagnostics, cancer diagnostics, down streaming processes such as protein purification for studying protein function and structure, mRNA transcriptome determination, drug screening, and analysis of the composition of specific proteins, nucleic acids, lipids individually or as complexes.

Market Dynamics

Global cell lysis market is projected to witness significant growth over the forecast period, owing to increasing prevalence of infectious diseases such as influenza, hepatitis, and other such diseases. For instance, according to data provided by Centers for Disease Control and Prevention (CDC) report 2022, a total of 4,702 laboratory-confirmed influenza-associated hospitalizations were reported by FluSurv-NET sites, CDC's source for important data on hospitalization rates associated with flu, between October 1, 2021, and May 28, 2022 in the U.S.

Key features of the study:

• This report provides in-depth analysis of the global cell lysis market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cell lysis market  based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Merck KgaA, QIAGEN, Roche Molecular Systems, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., and Qsonica 
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global cell lysis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell lysis market

Detailed Segmentation:

• Global Cell Lysis Market, By Product Type:
  • Instruments
  • Consumables   
• Global Cell Lysis Market, By Cell Type:
  • Mammalian Cells
  • Microbial Cells
  • Other Cells
• Global Cell Lysis Market, By End User:
  • Academic and Research Labs
  • Pharmaceutical and Biotechnology Companies
• Global Cell Lysis Market, By Region:
  • North America
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Region/Country
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • Becton, Dickinson and Company
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • QIAGEN
  • Roche Molecular Systems, Inc.
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Qsonica

“*” marked represents similar segmentation in other categories in the respective section.